Durham, NC, United States of America

Christopher P Lauderman


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher P. Lauderman: Innovator in Angiogenesis Modulation

Introduction

Christopher P. Lauderman is a notable inventor based in Durham, NC, recognized for his significant contributions to the field of medicinal chemistry. With a focus on developing innovative solutions for hyperproliferative diseases, his work stands out in the realm of pharmaceutical advancements.

Latest Patents

Lauderman holds one patent that is pivotal in the pharmacological landscape. The patent, titled "Pyrimidineamines as Angiogenesis Modulators," details pyrimidine derivatives that serve as inhibitors for the vascular endothelial growth factor receptor 2 (VEGFR2). This invention outlines not only the synthesis methods for these compounds but also their therapeutic applications in treating various hyperproliferative conditions.

Career Highlights

Christopher P. Lauderman is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role involves utilizing his expertise in chemical research and drug development, aimed at formulating effective treatments that can improve patient outcomes. His contributions within GlaxoSmithKline have been fundamental in addressing complex medical challenges through innovative drugs.

Collaborations

Throughout his career, Lauderman has collaborated with esteemed colleagues such as Amogh Boloor and Mui Cheung. These partnerships reflect a collective commitment to advancing research and development in pharmaceuticals, ensuring comprehensive approaches to tackling health issues related to angiogenesis.

Conclusion

Christopher P. Lauderman exemplifies the spirit of innovation in the pharmaceutical industry through his pioneering work on pyrimidine derivatives. His patent on angiogenesis modulators showcases his ability to translate scientific research into practical applications that have the potential to make a real difference in the treatment of serious health conditions. As a dedicated professional at GlaxoSmithKline LLC, Lauderman continues to influence the future of medicine through his inventive contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…